Total planned funding: $1,224,955,248
Clear active filters
Chemonics International
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
Nigeria | $269,958,959 |
Zambia | $214,327,457 |
Tanzania | $173,063,127 |
Mozambique | $132,859,439 |
Uganda | $108,394,760 |
Zimbabwe | $53,566,253 |
Rwanda | $49,875,893 |
Haiti | $47,944,197 |
Democratic Republic of the Congo | $43,359,367 |
Ethiopia | $19,704,263 |
South Africa | $16,642,059 |
Cameroon | $14,714,148 |
Côte d'Ivoire | $12,119,352 |
Malawi | $11,409,150 |
Eswatini | $7,635,838 |
Western Hemisphere Region | $7,512,526 |
Namibia | $6,152,831 |
Burundi | $6,108,947 |
West Africa Region | $5,461,164 |
Kenya | $5,308,353 |
Lesotho | $4,742,370 |
Asia Regional Program | $4,135,000 |
Ukraine | $4,052,913 |
Vietnam | $1,866,581 |
Botswana | $1,854,918 |
Ghana | $1,010,959 |
South Sudan | $445,752 |
Angola | $370,256 |
enumerations.Philippines | $358,416 |
Organizational Types
Private Contractor | $1,224,955,248 |
Program Areas
Treatment | $1,008,950,324 |
Care | $80,587,358 |
Prevention | $63,287,800 |
Governance and Systems | $55,487,587 |
Testing | $15,631,220 |
Budget Codes
HTXD: Treatment: ARV Drugs | $711,376,723 |
HTXS: Treatment: Adult Treatment | $271,776,085 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $48,905,709 |
OHSS: Health Systems Strengthening | $42,321,707 |
HVTB: Care: TB/HIV | $29,233,010 |
PDTX: Treatment: Pediatric Treatment | $25,797,516 |
HBHC: Care: Adult Care and Support | $25,490,337 |
PDCS: Care: Pediatric Care and Support | $22,265,710 |
HVCT: Testing: HIV Testing and Counseling | $15,631,220 |
HLAB: Laboratory Infrastructure | $10,251,306 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $6,597,068 |
HVOP: Sexual Prevention: Other Sexual Prevention | $5,540,102 |
HKID: Care: Orphans and Vulnerable Children | $3,598,301 |
HVSI: Strategic Information | $2,914,574 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $1,424,921 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $820,000 |
HMBL: Biomedical Prevention: Blood Safety | $0 |
HMIN: Biomedical Prevention: Injection Safety | $0 |
Top Partner Programs
Chemonics International:
$1,224,955,248
View countries